title: [Multidrug resistance: a century after "606"].
authors.affiliation: lllyrp@quetzal.innsz.mx
authors.forename: L
authors.initials: L
authors.lastname: Llorente
authors.forename: Y
authors.initials: Y
authors.lastname: Richaud-Patin
authors.forename: J
authors.initials: J
authors.lastname: Jakez-Ocampo
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D000328:Adult; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001153:Arsphenamine / Q000266:history; D001327:Autoimmune Diseases / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D004351:Drug Resistance; D018432:Drug Resistance, Multiple; D004357:Drug Synergism; D005260:Female; D019450:Genes, MDR; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy; D014700:Verapamil / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000893:Anti-Inflammatory Agents; D002121:Calcium Channel Blockers; D001153:Arsphenamine; D014700:Verapamil; D011241:Prednisone